225 related articles for article (PubMed ID: 35887565)
1. Pharmacogenomics of Leukotriene Modifiers: A Systematic Review and Meta-Analysis.
Zhao Y; Zhang X; Han C; Cai Y; Li S; Hu X; Wu C; Guan X; Lu C; Nie X
J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887565
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review.
Farzan N; Vijverberg SJ; Arets HG; Raaijmakers JA; Maitland-van der Zee AH
Clin Exp Allergy; 2017 Feb; 47(2):271-293. PubMed ID: 27790783
[TBL] [Abstract][Full Text] [Related]
3. The -444A/C polymorphism in the LTC4S gene and the risk of asthma: a meta-analysis.
Zhang Y; Huang H; Huang J; Xiang Z; Yang M; Tian C; Fan H
Arch Med Res; 2012 Aug; 43(6):444-50. PubMed ID: 22884858
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
6. Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.
Lima JJ
Mol Diagn Ther; 2007; 11(2):97-104. PubMed ID: 17397245
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the PTGDR and LTC4S influence responsiveness to leukotriene receptor antagonists in Korean children with asthma.
Kang MJ; Kwon JW; Kim BJ; Yu J; Choi WA; Shin YJ; Hong SJ
J Hum Genet; 2011 Apr; 56(4):284-9. PubMed ID: 21307858
[TBL] [Abstract][Full Text] [Related]
8. Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies.
Thompson MD; Capra V; Clunes MT; Rovati GE; Stankova J; Maj MC; Duffy DL
Front Pharmacol; 2016; 7():299. PubMed ID: 27990118
[TBL] [Abstract][Full Text] [Related]
9. Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.
Sánchez-Martín A; García-Sánchez A; Isidoro-García M
Methods Mol Biol; 2016; 1434():255-72. PubMed ID: 27300544
[TBL] [Abstract][Full Text] [Related]
10. Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis.
Halpern MT; Khan ZM; Stanford RH; Spayde KM; Golubiewski M
J Fam Pract; 2003 May; 52(5):382-9. PubMed ID: 12737772
[TBL] [Abstract][Full Text] [Related]
11. [Association of leukotriene gene polymorphisms with response to antileukotriene treatment in patients with asthma].
Cai C; Zhou MX; Li YP; Chen CS
Zhonghua Jie He He Hu Xi Za Zhi; 2011 May; 34(5):362-6. PubMed ID: 21729626
[TBL] [Abstract][Full Text] [Related]
12. Analysis of 927T> C CYSLTRI and -444A > C LTC4S polymorphisms in patients with asthma.
Sanz C; Isidro-García M; Dávila I; Moreno E; Laffond E; Lorente F
J Investig Allergol Clin Immunol; 2006; 16(6):331-7. PubMed ID: 17153879
[TBL] [Abstract][Full Text] [Related]
13. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma.
Lima JJ; Zhang S; Grant A; Shao L; Tantisira KG; Allayee H; Wang J; Sylvester J; Holbrook J; Wise R; Weiss ST; Barnes K
Am J Respir Crit Care Med; 2006 Feb; 173(4):379-85. PubMed ID: 16293801
[TBL] [Abstract][Full Text] [Related]
14. Association of Leukotriene C4 Synthase A-444C Polymorphism with Asthma and Asthma Phenotypes in Romanian Population.
Berghea EC; Popa LO; Dutescu MI; Meirosu M; Farcasanu IC; Berghea F; Bara C; Popa OM
Maedica (Bucur); 2015 Jun; 10(2):91-96. PubMed ID: 28275397
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy.
García-Menaya JM; Cordobés-Durán C; García-Martín E; Agúndez JAG
Front Pharmacol; 2019; 10():520. PubMed ID: 31178722
[TBL] [Abstract][Full Text] [Related]
16. Implications of pharmacogenomics in the current and future treatment of asthma.
Morrow T
J Manag Care Pharm; 2007; 13(6):497-505. PubMed ID: 17672811
[TBL] [Abstract][Full Text] [Related]
17. Lack of an association between a newly identified promoter polymorphism (-1702G > A) of the leukotriene C4 synthase gene and aspirin-intolerant asthma in a Korean population.
Choi JH; Kim SH; Bae JS; Yu HL; Suh CH; Nahm DH; Park HS
Tohoku J Exp Med; 2006 Jan; 208(1):49-56. PubMed ID: 16340173
[TBL] [Abstract][Full Text] [Related]
18. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
19. Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma.
Chauhan BF; Ben Salah R; Ducharme FM
Cochrane Database Syst Rev; 2013 Oct; (10):CD009585. PubMed ID: 24089325
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic and pharmacogenomic considerations of asthma treatment.
Matera MG; Rinaldi B; Calzetta L; Cazzola M
Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1159-1167. PubMed ID: 28992739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
